Patents by Inventor Timothy A. Denton

Timothy A. Denton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11966880
    Abstract: Techniques for building, validating, and utilizing custom database software in a shared management environment are described. A database customization service allows users to provide database installation files as part of a configuration to generate a custom database engine version. The creation of custom database engine versions may be governed by policy, and the database customization service may provide recommendations for creating custom database engine versions according to various criteria. The custom database engine version can be built, and its functionality and correctness verified. Users may launch database instances using these custom database engine versions that can be managed under a shared management scheme where both users and the database customization service can perform host-level management.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: April 23, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Dallas Lamont Willett, Mostafa G. Ead, Nitin Kumar Saxena, Lakshman Potluri, Oleg Leizerov, Prudhvi Janga, Bharath Subramanian Pichai, Timothy David Ebringer, Xin Zhao, Jason Denton
  • Patent number: 6094593
    Abstract: A method for detecting a heart disorder comprises examination of a phase-plane plot (PPP) of a patient electrocardiogram (EKG). The PPP's degree of deterministic chaos may be measured by a processor. Analysis of the PPP may indicate a propensity for fibrillation that is, indicate both the risk of fibrillation and its actual onset (cases where risk is 100 percent). A second method for detecting a heart disorder comprises examination of a frequency-domain transform (such as an FFT) of a patient EKG. An automatic defibrillating device may comprise means for delivering a variable shock, the size of which is determined at least in part by the FFT's peak energy. A method for detecting drug toxicity comprises examination of a parameter time constant for an action-potential duration (APD) restitution curve which is constructed for the patient.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: July 25, 2000
    Assignee: Cedars-Sinai Medical Center
    Inventors: Hrayr S. Karagueuzian, George A. Diamond, Steven S. Khan, Timothy A. Denton, Steven Evans
  • Patent number: 6021345
    Abstract: A method for detecting a heart disorder comprises examination of a phase-plane plot (PPP) of a patient electrocardiogram (EKG). The PPP's degree of deterministic chaos may be measured by a processor. Analysis of the PPP may indicate a propensity for fibrillation, that is, indicate both the risk of fibrillation and its actual onset (cases where risk is 100 percent). A second method for detecting a heart disorder comprises examination of a frequency-domain transform (such as an FFT) of a patient EKG. An automatic defibrillating device may comprise means for delivering a variable shock, the size of which is determined at least in part by the FFT's peak energy. A method for detecting drug toxicity comprises examination of a parameter time constant for an action-potential duration (APD) restitution curve which is constructed for the patient.
    Type: Grant
    Filed: August 28, 1996
    Date of Patent: February 1, 2000
    Assignee: Cedars-Sinai Medical Center
    Inventors: Hrayr S. Karagueuzian, Timothy A. Denton
  • Patent number: 5678561
    Abstract: A method for detecting a heart disorder comprises examination of a phase-plane plot (PPP) of a patient electrocardiogram (EKG). The PPP's degree of deterministic chaos may be measured by a processor. Analysis of the PPP may indicate a propensity for fibrillation, that is, indicate both the risk of fibrillation and its actual onset (cases where risk is 100 percent). A second method for detecting a heart disorder comprises examination of a frequency-domain transform (such as an FFT) of a patient EKG. An automatic defibrillating device may comprise means for delivering a variable shock, the size of which is determined at least in part by the FFT's peak energy. A method for detecting drug toxicity comprises examination of a parameter time constant for an action-potential duration (APD) restitution curve which is constructed for the patient.
    Type: Grant
    Filed: December 11, 1995
    Date of Patent: October 21, 1997
    Assignee: Cedars-Sinai Medical Center
    Inventors: Hrayr S. Karagueuzian, George A. Diamond, Steven S. Khan, Timothy A. Denton, Steven Evans
  • Patent number: 5643325
    Abstract: A method for detecting a heart disorder comprises examination of a phase-plane plot (PPP) of a patient electrocardiogram (EKG). The PPP's degree of deterministic chaos may be measured by a processor. Analysis of the PPP may indicate a propensity for fibrillation that is, indicate both the risk of fibrillation and its actual onset (cases where risk is 100 percent). A second method for detecting a heart disorder comprises examination of a frequency-domain transform (such as an FFT) of a patient EKG. An automatic defibrillating device may comprise means for delivering a variable shock, the size of which is determined at least in part by the FFT's peak energy. A method for detecting drug toxicity comprises examination of a parameter time constant for an action-potential duration (APD) restitution curve which is constructed for the patient.
    Type: Grant
    Filed: January 24, 1996
    Date of Patent: July 1, 1997
    Assignee: Cedars-Sinai Medical Center
    Inventors: Hrayr S. Karagueuzian, George A. Diamond, Steven S. Khan, Timothy A. Denton, Steven Evans
  • Patent number: 5555889
    Abstract: A method for detecting a heart disorder comprises examination of a phase-plane plot (PPP) of a patient electrocardiogram (EKG). The PPP's degree of deterministic chaos may be measured by a processor. Analysis of the PPP may indicate a propensity for fibrillation, that is, indicate both the risk of fibrillation and its actual onset (cases where risk is 100 percent). A second method for detecting a heart disorder comprises examination of a frequency-domain transform (such as an FFT) of a patient EKG. An automatic defibrillating device may comprise means for delivering a variable shock, the size of which is determined at least in part by the FFT's peak energy. A method for detecting drug toxicity comprises examination of a parameter time constant for an action-potential duration (APD) restitution curve which is constructed for the patient.
    Type: Grant
    Filed: February 4, 1994
    Date of Patent: September 17, 1996
    Assignee: Cedars-Sinai Medical Center
    Inventors: Hrayr S. Karagueuzian, George A. Diamond, Steven S. Khan, Timothy A. Denton, Steven Evans